Opioid-induced hyperalgesia: Fact or fiction?

Palliative Medicine

Volumn 22, Issue 1, 2008, Pages 5-6

  Fallon, Marie ^a   Colvin, Lesley ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE 3 GLUCURONIDE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PHENANTHRENE DERIVATIVE; PROSTAGLANDIN; PROTEIN KINASE C;

AGITATION; ANALGESIC ACTIVITY; ANTINOCICEPTION; CANCER PAIN; CONFUSION; DISEASE PREDISPOSITION; DISTRESS SYNDROME; DROWSINESS; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG TOLERANCE; EDITORIAL; HALLUCINATION; HUMAN; HYPERALGESIA; INCIDENCE; LOW DRUG DOSE; MYOCLONUS; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PAIN; PALLIATIVE THERAPY; PROGNOSIS; SIDE EFFECT; SIGNAL TRANSDUCTION; VIVID DREAM;

ANALGESICS, OPIOID; HUMANS; HYPERALGESIA;

EID: 40449134877     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216307086857     Document Type: Editorial

References (15)

1. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002; 23: 131-7.
2. Mao J. Opioid-induced abnormal pain sensitivity: Implications in clinical opioid therapy. Pain 2002; 100: 213-7.
3. Fine PG. Opioid insights: Opioid-induced hyperalgesia and opioid rotation. J Pain Palliat Care Pharmacother 2004; 18: 75-9.
4. Simonnet G, Rivat C. Opioid-induced hyperalgesia: abnormal or normal pain? Neuroreport 2003; 14: 1-7.
5. Angst MS, Clark JD. Opioid-induced Hyperalgesia: a qualitative systematic review. Anesthesiology 2006; 104: 570-87.
6. Penson RT, Joel SP, Gloyne A, Clark S, Slevin ML. Morphine analgesia in cancer pain: role of the glucuronides. J Opioid Manag 2005; 1(2): 83-90.
7. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am 2007; 91: 199-211.
8. Colpaert FC, Deseure K, Stinus L et al. High-efficacy 5-hydroxytryptamine 1A receptor activation counteracts opioid hyperallodynia and affective conditioning. J Pharmacol Exp Ther 2006; 316: 892-9.
9. Compton P, Geschwind DH, Alarcon M. Association between human mu-opioid receptor gene polymorphism, pain tolerance, and opioid addiction. Am J Med Genet B Neuropsychiatr Genet 2003; 121: 76-82.
10. Crain SM, Shen KF. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naive mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice. Brain Res 2007; 1167: 31-41.
11. Gardell LR, King T, Ossipov MH et al. Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett 2006; 396: 44-9.
12. Grecksch G, Bartzsch K, Widera A et al. Development of tolerance and sensitization to different opioid agonists in rats. Psychopharmacology 2006; 186: 177-84.
13. Li X, Angst MS, Clark JD. A murine model of opioid-induced hyperalgesia. Brain Res Mol Brain Res 2001; 86: 56-62.
14. Mercadante S, Arcuri E. Hyperalgesia and opioid switching. Am J Hospice Palliative Care 2005; 22: 291-4.
15. Reznikov I, Pud D, Eisenberg E. Oral opioid administration and hyperalgesia in patients with cancer or chronic nonmalignant pain. Brit J Clin Pharmacol 2005; 60: 311-8.